[1] Nunomura A, Perry G, Aliev G, et al. Oxidative damage is the earliest event in Alzheimer disease[J]. J Neuropathol Exp Neurol, 2001, 60(8):759-767. [2] Sung S, Yayo Y, Yang H, et al. Early Vitamin E supplementation in young but no aged mice reduces Aβ levels and amyloid deposition in a transgenic model of Alzheimer' s disease[J]. FASEB J, 2004, 18(2):323-325. [3] Sommer C, Schomacher M, Berger C, et al. Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra[J]. Stroke, 2006, 112(3):277-286. [4] Zhang D, Liu GT, Shi JG, et al. Effects of Coeloglossum .viride var.bracteatum extract on memory deficits and pathological changes in senescent mice[J]. Basic Clin Pharmacol Toxicol, 2006, 98(1):55-60. [5] Conte V, Uryu K, Fujimoto S, et al. Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury[J]. J Neurochem, 2004, 90(3):758-764. [6] Drake J, Link CD, Butterfield DA.Oxidative stress precedes fibrillar deposition of Alzheimer' s disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model[J]. Neurobiol Aging, 2003, 24(3):415-420. [7] Cui X, Zuo P, Zhang Q, et al. Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice:protective effects of R-alpha-lipoic acid[J]. J Neurosci Res, 2006, 84(3):647-654. [8] Bard F, Barbour R, Cannon C, et al. Epitope and isotype specificities of antibodies to beta-amyloid peptide for protectionagainst Alzheimer' s disease-like neuropathology[J]. Proc Natl Acad Sci USA, 2003, 100(4):2023-2028. [9] Masliah E, Hansen L, Adame A, et al. Abeta vaccination effects on plaque pathology in theabsence of encephalitis in Alzheimer disease[J]. Neurology, 2005, 64(1):129-131. [10] Atack JR, Perry EK, Bonham JR, et al. Molecular forms of acetylcholinesterasein senile dementia of Alzheimer' s type:selective loss of the intermediate (10S) form[J]. Neurosci Lett, 1983, 40(2):199-204. [11] Ulrich J, Meier-Ruge W, Probst A, et al. Senile plaques:staining for acetylcholinesterase and A4 protein: acomparative study in the hippocampus and entorhinal cortex[J]. Acta Neuropathol, 1990, 80(6):624-628. [12] Melo JB, Agostinho P, Oliveira CR.Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amy loid beta-peptide[J]. Neurosci Res,2003, 45(1):117-127. [13] Yoshiyama Y, Arai K, Hattori T.Enhanced expression of I-kappaB with neurofibrillary pathology in Alzheimer' s disease[J]. Neuroreport, 2001, 12(12):2641-2645. [14] Paris D, Patel N, Quadros A, et al. Inhibition of Abeta production by NF-kappaB inhibitors[J]. Neurosci Lett,2007, 415(1):11-16. |